Thromboelastography evaluation of tissue plasminogen activator therapy in a cat with acute aortic thromboembolism due to hypertrophic cardiomyopathy

Yıl 2023, Cilt: 2 Sayı: 1, 10 - 16, 28.10.2023

Meriç Kocatürk Pınar Levent Zeki Yılmaz

Öz

Acute arterial thromboembolism (ATE) is a very painful and fatal serious condition in which the thrombus lodges in the trifurcation of the aorta, resulting in death or severe damage to organs if not treated immediately. Thrombolytic agents such as tissue plasminogen activator (tPA) are preferred as a first choice of the treatment for ATE; however, they should be used carefully because of their possible side effects such as spontaneous bleeding in human and animals. Therefore, monitoring coagulation status plays an important role in the management and treatment of dissolving intravascular clots. Thromboelastography (TEG) that measures the dynamics of clot formation, strength, and lysis, and provides information of clot consistency has been accepted as a useful tool for assessing coagulation status and response to thrombolytic therapy. There is no study showing the thromboelastographic monitoring of the thrombolytic therapy with intravenous tPA in cats. Therefore, we reported here a successful thrombolysis using tPA and for the first time monitoring the lytic treatment by TEG in a cat with ATE due to hypertrophic cardiomyopathy (HCM).

Anahtar Kelimeler

Acute aortic thromboembolism, thromboelastography, tissue plasminogen activator, cat.

Hipertrofik kardiyomiyopatiye bağlı akut aortik tromboembolisi olan bir kedide doku plazminojen aktivatörü tedavisinin tromboelastografi ile değerlendirilmesi

Öz

Akut arteriyel tromboembolizm (ATE), trombusun aortun trifürkasyonuna yerleştiği, hemen tedavi edilmezse ölüme veya organlarda ciddi hasara yol açan çok ağrılı ve ölümcül ciddiyetli bir durumdur. ATE tedavisinde ilk seçenek olarak doku plazminojen aktivatörü (tPA) gibi trombolitik ajanlar tercih edilmektedir; ancak insan ve hayvanlarda spontan kanama gibi olası yan etkileri nedeniyle dikkatli kullanılmaları gerekir. Bu nedenle pıhtılaşma durumunun izlenmesi, çözünen intravasküler pıhtıların yönetimi ve tedavisinde önemli bir rol oynar. Pıhtı oluşumu, gücü ve lizis dinamiklerini ölçen ve pıhtı tutarlılığı hakkında bilgi sağlayan tromboelastografi (TEG), pıhtılaşma durumunu ve trombolitik tedaviye yanıtı değerlendirmede yararlı bir araç olarak kabul edilmiştir. Kedilerde intravenöz tPA ile uygulanan trombolitik tedavinin tromboelastografik takibini gösteren bir çalışma bulunmamaktadır. Bu nedenle burada hipertrofik kardiyomiyopatiye (HCM) bağlı ATE'li bir kedide tPA kullanılarak başarılı bir trombolizi rapor ettik ve ilk kez TEG ile trombolitik tedaviyi izledik.

Anahtar Kelimeler

Akut aortik tromboembolis, tromboelastografi, doku plazminojen aktivatörü, kedi.

Kaynakça

• 1. Payne J., Borgeat K., Brodbelt D.C., Connolly D.J., Luis Fuentes V.: Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy. J. Vet. Cardiol. 2015, (17): 318-328.
• 2. Whelan M., O’Toole T.: The use of thrombolytic agents. Compendium. 2007; 29: 28.
• 3. Niedermeyer J., Meissner E., Fabel H.: Thrombolytic therapy in pulmonary embolism. Indications and therapeutic strategies. Z. Gesamte Inn. Med. 1993, 48(6-7): 332-43.
• 4. Heiferman D.M., Li D.D., Pecoraro N.C., Smolenski A.M., Tsimpas A., Ashley W.W.: Intra-Arterial Alteplase Thrombolysis during Mechanical Thrombectomy for Acute Ischemic Stroke. J. Stroke Cerebrovasc. Dis. 2017, 26(12): 3004-3008.
• 5. Borgeat K., Wright J., Garrod O., Payne J.R., Fuentes V.L.: Arterial Thromboembolism in 250 Cats in General Practice: 2004–2012. J. Vet. Intern. Med. 2014; 28(1): 102-108.
• 6. Fuentes V.L.: Arterial Thromboembolism: Risks, realities and a rational first-line approach. J. Feline Med. Surg. 2012, 14 (7): 459-470.
• 7. Fuentes V.L., Abbott J., Chetboul V., Côté E., Fox P.R., Häggström J., Kittleson M.D., Schober K., Stern J.A.: ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. J. Vet. Intern. Med. 2020, 1-16.
• 8. Martin U., Sponer G., Strein K.: Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis. J. Am. Coll. Cardiol. 1992, 19(2): 433-40.
• 9. Diaz D.M., Scansen B.A., Lake Z., Shropshire S., Orton E.C., Guillaumin J.: Clinical use of tissue plasminogen activator for systemic thrombolysis in dogs and cats. J. Vet. Cardiol. 2022, 41: 154-164.
• 10. Sutton B., Long Mays E., McLaughlin C.: Case Report: Successful Reperfusion of Pulmonary Thromboembolism Using tPA in a Cat. Front. Vet. Sci. 2022, 20(9): 851106.
• 11. Moore K., Morris N., Dhupa N., Murtaugh R., Rush J.: Retrospective Study of Streptokinase Administration in 46 Cats with Arterial Thromboembolism. J. Vet. Emerg. Crit. Care. 2000, 10: 245-257.
• 12. White H.D.: Comparison of tissue plasminogen activator and streptokinase in the management of acute myocardial infarction. Chest. 1989, 95(5 Suppl): 265S-269S.
• 13. Gravanis I., Tsirka S.E.: Tissue-type plasminogen activator as a therapeutic target in stroke. Expert Opin. Ther. Targets. 2008, 12(2): 159-70.
• 14. Bauer N., Eralp O., Moritz A.: Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J. Vet. Diagn. Invest. 2009, 21: 641-648.
• 15. Marschner C.B., Bjørnvad C.R., Kristensen A.T., Wiinberg B.: Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet. Scand. 2010, 52(1): 38.
• 16. Eralp O., Yilmaz Z., Failing K., Moritz A., Bauer N.: Effect of experimental endotoxemia on thromboelastography parameters, secondary and tertiary hemostasis in dogs. J.Vet. Intern. Med. 2011, 25: 524-531.
• 17. Lubas G., Caldin M., Wiinber B., Kristensen A.T.: Laboratory Testing of Coagulation Disorders. In: Weiss DJ, Wardrop KJ, editors. Schalm’s Veterinary Hematology. 6th ed. Ames, IA, USA: Wiley-Blackwell, 2010, sayfa: 1082-1100.
• 18. Elliott A., Wetzel J., Roper T., Pivalizza E., McCarthy J., Wallace C., Hess M.J., Peng H., Rahbar M.H., Sangha N., Grotta J.C.: Thromboelastography in patients with acute ischemic stroke. Int. J. Stroke. 2015, 10(2): 194-201.
• 19. Bae J., Kim H., Kim W., Kim S., Park J., Jung D.I., Yu D.: Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time. J. Vet. Intern. Med. 2019, 33(3): 1322-1330.
• 20. Alwood A.J., Downend A.B., Brooks M.B., Slensky K.A., Fox J.A., Simpson S.A., Waddell L.S., Baumgardner J.E., Otto C.M.: Anticoagulant effects of low-molecular-weight heparins in healthy cats. J. Vet. Intern. Med. 2007, 21(3): 378-87.
• 21. Col R., Montgomery A., Maria C.I., Defelice A., Saavedra P.V., Couto G.: Whole-blood thromboelastography using calcium chloride activation in healthy cats. Turkish J. Vet. Anim. Sci. 2013, 37: 68-75.
• 22. Bjornvad C.R., Wiinberg B., Kristensen A.T.: Obesity increases initial rate of fibrin formation during blood coagulation in domestic shorthaired cats. J. Anim. Physiol. Anim. Nutr (Berl). 2012, 96: 834-841.
• 23. Muri B.M., Jud Schefer R., Sigrist N.E.: Serial evaluation of haemostasis following acute trauma using rotational thromboelastometry in cats. Vet. Comp. Orthop. Traumatol. 2019, 32: 289-296.
• 24. Cui Y., Heuser K., Bauer N., Neiger R.: Coagulation parameters in hyperthyroid cats before and after radioiodine treatment compared with healthy controls. J. Feline. Med. Surg. 2019, 21(12): 1134-1140.
• 25. Conner B.J., Hanel R.M., Brooks M.B., Cohn L.A., Birkenheuer A.J.: Coagulation abnormalities in 5 cats with naturally occurring cytauxzoonosis. J. Vet. Emerg. Crit. Care (San Antonio). 2015, 25(4): 538-45.
• 26. Fiakpui N.N., Hogan D.F., Whittem T., Green H.W. 3rd, Shipley E.A., Sederquist K.A.: Dose determination of fondaparinux in healthy cats. Am. J. Vet. Res. 2012, 73(4): 556-61.
• 27. Reed M., Kerndt C.C., Nicolas D.: Alteplase. [Updated 2022 Jul 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-Available from: https://www.ncbi.nlm.nih.gov/books/NBK499977/
• 28. Guillaumin J., DeFrancesco T.C., Scansen B.A., Quinn R., Whelan M., Hanel R., Goy-Thollot I., Bublot I., Robertson J.B., Bonagura J.D.: Bilateral lysis of aortic saddle thrombus with early tissue plasminogen activator (BLASTT): a prospective, randomized, placebo-controlled study in feline acute aortic thromboembolism. J. Feline Med. Surg. 2022, 24(12): e535-e545.
• 29. Hall D.J., Rush J.E., deLaforcade A.M., Shaw S.P.: Kaolin-activated thromboelastography in echocardiographically normal cats. Am. J. Vet. Res. 2012, 73(6): 775-778.
• 30. Kakar N., Daniel G., Fellman C., de Laforcade A., Webster C.R.: Thromboelastography in cats with cholestatic liver disease. J. Feline Med. Surg. 2021, 23(2):160-167.
• 31. Yılmaz Z., Kocatürk M., İnan O.E., Levent P.: Thromboelastographic Evaluation of Hemostatic Functionin Dogs with Dilated Cardiomyopathy. Turkish J. Vet. Anim Sci. 2017, 41(3): 372-379.
• 32. Boon J.A.: Veterinary Echocardiography. 2nd ed., USA, Wiley-Blackwell; 2010.
• 33. Ware W.A.: Cardiovascular Disease in Small Animal Medicine. UK, Manson Publishing; 2011.
• 34. Pouzot-Nevoret C., Barthélemy A., Goy-Thollot I., Boselli E., Cambournac M., Guillaumin J., Bonnet-Garin J.M., Allaouchiche B.: Infrared thermography: a rapid and accurate technique to detect feline aortic thromboembolism. J. Feline Med. Surg. 2018, 20(8): 780-785.
• 35. Salcı H., Kocatürk M., İpek V., Çetin M., Kahraman M.M., Yılmaz Z.: Echocardiographic, Magnetic Resonance Angiography and Pathologic Results of an Iliac Arterial Thromboembolism (Saddle Thrombus) in a Cat. Kafkas Univ. Vet. Fak. Derg. 2016, 22 (6): 977-978.
• 36. Engelen C., Moritz A., Barthel F., Bauer N.: Preliminary reference intervals and the impact of citrate storage time for thrombelastography in cats including delta and the velocity curve. BMC Vet. Res. 2017, 29; 13(1): 366.
• 37. Guillaumin J., Gibson R.M., Goy-Thollot I., Bonagura J.D.: Thrombolysis with tissue plasminogen activator (TPA) in feline acute aortic thromboembolism: a retrospective study of 16 cases. J. Feline Med. Surg. 2019, 21(4): 340-346.
• 38. Silva D.M., Caramalac S.M., Caramalac S.M., Gimelli A., Palumbo M.I.P.: Feline Aortic Thromboembolism Diagnosed by Thermography. Acta Sci. Vet. 2022, 50(Suppl 1): 752.
• 39. Vezzosi T., Buralli C., Briganti A., Vannozzi I., Giacomelli E., Talamanca G.F., Sansoni A., Domenech O., Tognetti R.: Surgical embolectomy in a cat with cardiogenic aortic thromboembolism. J. Vet. Cardiol. 2020, 28: 48-54.
• 40. Sharifi M., Bay C., Nowroozi S., Bentz S., Valeros G., Memari S.: Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis. Cardiovasc. Intervent. Radiol. 2013, 36(6): 1586-1590.
• 41. Demaerschalk B.M., Kleindorfer D.O., Adeoye O.M., Demchuk A.M., Fugate J.E., Grotta J.C., Khalessi A.A., Levy E.I., Palesch Y.Y., Prabhakaran S., Saposnik G., Saver J.L., Smith E.E.: American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2016, 47(2): 581-641.
• 42. Hossain S., Sar- kar B., Prottoy N.I., Araf Y., Taniya M.A., Ullah A.: Thrombolytic Activity, Drug Likeness Property and ADME/T Analysis of Isolated Phytochemicals from Ginger (Zingiber officinale) Using in Silico Approaches. Modern Res. Inflamm. 2019, 8: 29-43.